the MRC Pilot Study safe and achieves a high percentage of molecular responses. Results of Autografting for younger patients with chronic lymphocytic leukaemia is

[1]  N. Schmitz,et al.  The prognostic impact of autologous stem cell transplantation in patients with chronic lymphocytic leukemia: a risk-matched analysis based on the VH gene mutational status. , 2004, Blood.

[2]  P. Feugier,et al.  Impact of frontline fludarabine and cyclophosphamide combined treatment on peripheral blood stem cell mobilization in B-cell chronic lymphocytic leukemia. , 2004, Blood.

[3]  S. Stilgenbauer,et al.  Unmutated immunoglobulin variable heavy-chain gene status remains an adverse prognostic factor after autologous stem cell transplantation for chronic lymphocytic leukemia. , 2003, Blood.

[4]  Lois Shepherd,et al.  Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study, cancer and leukemia group B 9011. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  E. Kimby,et al.  Standard‐dose anti‐CD20 antibody rituximab has efficacy in chronic lymphocytic leukaemia: results from a Nordic multicentre study , 2002, European journal of haematology.

[6]  Axel Benner,et al.  Stromal-derived factor 1 inhibits the cycling of very primitive human hematopoietic cells in vitro and in NOD/SCID mice. , 2002, Blood.

[7]  E. Kimby,et al.  Phase II trial of subcutaneous anti-CD52 monoclonal antibody alemtuzumab (Campath-1H) as first-line treatment for patients with B-cell chronic lymphocytic leukemia (B-CLL). , 2002, Blood.

[8]  L. Andritsos,et al.  Chronic lymphocytic leukemia , 2002, Current treatment options in oncology.

[9]  E. Montserrat,et al.  Autologous and allogeneic stem cell transplantation for chronic lymphocytic leukemia , 2002, Leukemia.

[10]  V. Diehl,et al.  Quantitative molecular monitoring of residual tumor cells in chronic lymphocytic leukemia , 2002, Annals of Hematology.

[11]  D. Oscier,et al.  CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease. , 2002, Blood.

[12]  J. Dürig,et al.  CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia , 2002, Leukemia.

[13]  P. Feugier,et al.  Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients. , 2001, Blood.

[14]  W. Stock,et al.  Allogeneic and autologous transplantation for chronic lymphocytic leukemia , 2001, Leukemia.

[15]  S. O'brien,et al.  Immunotherapy of chronic lymphocytic leukemia , 2001, Expert review of anticancer therapy.

[16]  T. Lister,et al.  Detection of chromosome abnormalities pre-high-dose treatment in patients developing therapy-related myelodysplasia and secondary acute myelogenous leukemia after treatment for non-Hodgkin's lymphoma. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  J. Esteve,et al.  Stem cell transplantation for chronic lymphocytic leukemia: different outcome after autologous and allogeneic transplantation and correlation with minimal residual disease status , 2001, Leukemia.

[18]  B. Cheson,et al.  Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia. , 2000, The New England journal of medicine.

[19]  G. Anger,et al.  Successful treatment and re-treatment of resistant B-cell chronic lymphocytic leukemia with the monoclonal anti-CD 20 antibody rituximab , 2000, Annals of Hematology.

[20]  N. Schmitz,et al.  Stem-cell transplantation for chronic lymphocytic leukemia: the 1999 perspective. , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

[21]  R. Foà,et al.  Unmanipulated peripheral blood stem cell autograft in chronic lymphocytic leukemia: clinical findings and biological monitoring. , 2000, Haematologica.

[22]  T. Lister,et al.  Factors which predict unsuccessful mobilisation of peripheral blood progenitor cells following G-CSF alone in patients with non-Hodgkin's lymphoma. , 2000, The hematology journal : the official journal of the European Haematology Association.

[23]  G. Ahsan,et al.  Dose intensification and molecular responses in patients with chronic lymphocytic leukaemia: a phase II single centre study , 1999, Bone Marrow Transplantation.

[24]  N. Chiorazzi,et al.  Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. , 1999, Blood.

[25]  N. Schmitz,et al.  Secondary leukaemia and myelodysplasia after autografting for lymphoma: results from the EBMT , 1999, British journal of haematology.

[26]  R. Foà,et al.  Clinical characteristics and outcome of young chronic lymphocytic leukemia patients: a single institution study of 204 cases. , 1999, Blood.

[27]  G. Martinelli,et al.  Fludarabine‐containing regimens severely impair peripheral blood stem cells mobilization and collection in acute myeloid leukaemia patients , 1999, British journal of haematology.

[28]  A. Freedman,et al.  Bone marrow transplantation for low-grade lymphoma and chronic lymphocytic leukemia. , 1999, Seminars in hematology (Print).

[29]  J. Gribben,et al.  Minimal residual disease detection after myeloablative chemotherapy in chronic lymphatic leukemia , 1999, Journal of Molecular Medicine.

[30]  J. Binet,et al.  Autologous hematopoietic stem cell transplantation as salvage treatment for advanced B cell chronic lymphocytic leukemia , 1998, Leukemia.

[31]  G. Salles,et al.  Factors associated with successful mobilization of peripheral blood progenitor cells in 200 patients with lymphoid malignancies , 1998, British journal of haematology.

[32]  C. D. Wu,et al.  High incidence of relapse after autologous stem-cell transplantation for B-cell chronic lymphocytic leukemia or small lymphocytic lymphoma. , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

[33]  E J Freireich,et al.  Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapy. , 1998, Blood.

[34]  N. Schmitz,et al.  leukaemia: a chance for cure? , 2022 .

[35]  M. Keating,et al.  Hematopoietic stem cell transplantation for chronic lymphocytic leukemia. , 1998, Current opinion in hematology.

[36]  F. Mandelli,et al.  Chronic lymphocytic leukemia: from palliative therapy to curative intent. , 1998, Haematologica.

[37]  D. Catovsky,et al.  Analysis of residual disease in chronic lymphocytic leukemia by flow cytometry , 1997, Leukemia.

[38]  N. Schmitz,et al.  The role of stem cell transplantation in the treatment of chronic lymphocytic leukemia. , 1997, Leukemia.

[39]  J. Hainsworth,et al.  Treatment-related mortality in 1000 consecutive patients receiving high-dose chemotherapy and peripheral blood progenitor cell transplantation in community cancer centers , 1997, Bone Marrow Transplantation.

[40]  J. Gribben,et al.  Eradication of polymerase chain reaction-detectable chronic lymphocytic leukemia cells is associated with improved outcome after bone marrow transplantation. , 1996, Blood.

[41]  M. Grever,et al.  National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. , 1996, Blood.

[42]  W. Hiddemann,et al.  Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia , 1996, The Lancet.

[43]  M. Dyer,et al.  Humanized CD52 monoclonal antibody campath‐1H as first‐line treatment in chronic lymphocytic leukaemia , 1996, British journal of haematology.

[44]  A. Tedeschi,et al.  Effectiveness of Fludarabine in Advanced B-Cell Chronic Lymphocytic Leukemia , 1995, Tumori.

[45]  J. Rutovitz,et al.  Autologous blood stem cell transplantation for haematological malignancy: treatment-related mortality of 2%. , 1995, Australian and New Zealand journal of medicine.

[46]  S. Molica,et al.  Prognostic features and therapeutical approaches in B-cell chronic lymphocytic leukemia: an update. , 1995, Haematologica.

[47]  W. Chan,et al.  Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[48]  B. Andersson,et al.  Autologous and allogeneic bone marrow transplantation for chronic lymphocytic leukemia: preliminary results. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[49]  M. J. Phillips,et al.  Absence of minimal residual disease detectable by FACS, Southern blot or PCR in patients with chronic lymphocytic leukaemia treated with fludarabine. , 1994, Acta oncologica.

[50]  D. Neuberg,et al.  Autologous and allogeneic bone marrow transplantation for poor prognosis patients with B-cell chronic lymphocytic leukemia. , 1993, Blood.

[51]  A. Tefferi,et al.  Prognostic features and survival in young adults with early/intermediate chronic lymphocytic leukemia (B-CLL): a single institution study. , 1993, Leukemia.

[52]  B. Barlogie,et al.  Fludarabine: a new agent with major activity against chronic lymphocytic leukemia. , 1989, Blood.

[53]  D. Catovsky,et al.  Prognostic factors in chronic lymphocytic leukaemia: the importance of age, sex and response to treatment in survival , 1989, British journal of haematology.

[54]  D. Catovsky,et al.  The UK Medical Research Council CLL trials 1 and 2. , 1988, Nouvelle revue francaise d'hematologie.

[55]  H. Kantarjian,et al.  Multiple agent chemotherapy (POACH) in previously treated and untreated patients with chronic lymphocytic leukemia. , 1988, Leukemia.

[56]  K. Rai,et al.  Comparison of daily versus intermittent chlorambucil and prednisone therapy in the treatment of patients with chronic lymphocytic leukemia. , 1977, Blood.